ghk cu dosing injection GHK-Cu Peptide Therapy: The Definitive Clinical Guide to Gene Modulation, Protocols, and Efficacy Is GHK-Cu actually worth it?”
Description
Michael Adams and Trish (Patricia) Dolan were funded in the UK by Action Medical Research, registration number 208701
Clinical trials have shown their efficacy and safety over several years, yet the possibility of long-term adverse effects remains a research focus
Enzyme kinetic studies in endothelial cell models demonstrate increased eNOS (endothelial nitric oxide synthase) activity following compound application
The absence of approval means there is no licensed manufacturer, no quality standards enforced by health authorities, and no legal framework for medical use
